|
Federal Register Search Results
CDER - March 2004
Federal Register, Volume 69 (2004)
3/1/04
Total Hits: 1
-
[1] fr01mr04N Determination That
Cytoxan (Cyclophosphamide for Injection), 2- Size: 7976 , Score: 338 , HTML
3/2/04
Total Hits: 0
3/3/04
Total Hits: 0
3/4/04
Total Hits: 0
3/5/04
Total Hits: 2
-
[1] fr05mr04N Draft Guidance
for Industry on Labeling for Combined Oral- Size: 4623 , Score: 544 , HTML
-
[2] fr05mr04N Diabetes: Targeting
Safe and Effective Prevention and Treatment;- Size: 8872 , Score: 491 , HTML
3/8/04
Total Hits: 2
-
[1] fr08mr04N Guidance for Federal
Agencies and State and Local Governments;- Size: 5466 , Score: 523 , HTML
-
[2] fr08mr04N Determination That
LOVENOX (Enoxaparin Sodium) 90 Milligrams/0.6- Size: 5207 , Score: 355 , HTML
3/9/04
Total Hits: 2
-
[1] fr09mr04N Draft Guidance
for Industry on Vaccinia Virus--Developing Drugs- Size: 5472 , Score: 708 , HTML
-
[2] fr09mr04N Antimicrobial Drug
Development; Public Workshop- Size: 4487 , Score: 547 , HTML
3/10/04
Total Hits: 1
-
[1] fr10mr04R Medical Device
Reports; Reports of Corrections and Removals;- Size: 25060 , Score: 1000 , HTML
3/11/04
Total Hits: 0
3/12/04
Total Hits: 0
3/15/04
Total Hits: 6
-
[1] fr15mr04N Report on the Performance
of Drug and Biologics Firms in- Size: 10554 , Score: 489 , HTML
-
[2] fr15mr04N Determination of
Regulatory Review Period for Purposes of Patent- Size: 6703 , Score: 427 , HTML
-
[3] fr15mr04N Determination of
Regulatory Review Period for Purposes of Patent- Size: 6754 , Score: 426 , HTML
-
[4] fr15mr04N Determination of
Regulatory Review Period for Purposes of Patent- Size: 6780 , Score: 425 , HTML
-
[5] fr15mr04N Determination of
Regulatory Review Period for Purposes of Patent- Size: 6924 , Score: 424 , HTML
-
[6] fr15mr04N Determination That
DIAZEPAM Injection United States Pharmacopeia- Size: 5364 , Score: 352 , HTML
3/16/04
Total Hits: 0
3/17/04
Total Hits: 0
3/18/04
Total Hits: 1
-
[1] fr18mr04R Prescription Drug
Marketing Act of 1987; Prescription Drug- Size: 20899 , Score: 737 , HTML
3/19/04
Total Hits: 1
-
[1] fr19mr04N Determination of
Regulatory Review Period for Purposes of Patent- Size: 6908 , Score: 425 , HTML
3/22/04
Total Hits: 1
-
[1] fr22mr04N Agency Information Collection Activities;
Proposed Collection;
- Size: 12327 , Score: 284
, HTML
3/23/04
Total Hits: 1
-
[1] fr23mr04R Change of Address; Technical Amendment
- Size: 3019 , Score: 230
, HTML
3/24/04
Total Hits: 4
-
[1] fr24mr04N Advisory Committee for Pharmaceutical
Science; Notice of Meeting
- Size: 4085 , Score: 221
, HTML
- [2] fr24mr04P Drug Labeling; Sodium Labeling for Over-the-Counter
Drugs
- Size: 24898 , Score: 213
, HTML
- [3] fr24mr04R Drug Labeling; Sodium Labeling for Over-the-Counter
Drugs;
- Size: 59533 , Score: 192
, HTML
- [4] fr24mr04R Drug Labeling; Orally Ingested Over-the-Counter
Drug Products
- Size: 72976 , Score: 188
, HTML
3/25/04
Total Hits: 0
3/26/04
Total Hits: 0
3/29/04
Total Hits: 0
3/30/04
Total Hits: 4
-
[1] fr30mr04N International Conference on Harmonisation;
Draft Guidance on E2E
- Size: 7510 , Score: 452
, HTML
- [2] fr30mr04N International Conference on Harmonisation;
Draft Guidance on Q5E
- Size: 8588 , Score: 440
, HTML
- [3] fr30mr04N Oncologic Drugs Advisory Committee;
Notice of Meeting
- Size: 4159 , Score: 219
, HTML
- [4] fr30mr04N Nonprescription Drugs Advisory Committee
and the Dermatologic and
- Size: 4104 , Score: 219
, HTML
3/31/04
Total Hits: 0
© 1997-2006 Betterchem
Corp.
|